Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Similar documents
Lessons learned From The National PCI Registry

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Unprotected LM intervention

The MAIN-COMPARE Study

PROMUS Element Experience In AMC

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

Cindy L. Grines MD FACC FSCAI

The MAIN-COMPARE Registry

LM stenting - Cypher

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

4. Which survey program does your facility use to get your program designated by the state?

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Alex versus Xience Registry Preliminary report

Final Kissing Ballooning Returns? The analysis of COBIS II registry

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Abstract Background: Methods: Results: Conclusions:

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

STEMI ST Elevation Myocardial Infarction

Perioperative Management After Coronary Stenting: Risk Assessment Before Surgery. Christian Seiler No conflict of interest to declare.

FFR-guided Jailed Side Branch Intervention

APPENDIX F: CASE REPORT FORM

Percutaneous Intervention of Unprotected Left Main Disease

A Polymer-Free Dual Drug-Eluting Stent in Patients with Coronary Artery Disease: Randomized Trial Versus Polymer-Based DES.

Patient characteristics Intervention Comparison Length of followup

Approach to Multi Vessel disease with STEMI

Korea University Guro Hospital, Seoul, Korea * Chonnam National University Hospital, Gwangju, Korea

Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

1. Diabetes mellitus (DM) is associated with worse clinical and angiographic outcomes even in acute myocardial Infarction (AMI) patients.

Acute Coronary Syndrome. Sonny Achtchi, DO

The Case for Multivessel Revascularization in Shock

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

Coronary Artery Stenosis. Insight from MAIN-COMPARE Study

DECISION - CTO. optimal Medical Treatment in patients with. Seung-Jung Park, MD, PhD, FACC for the DECISION-CTO Study investigators

Coronary Artery Disease: Revascularization (Teacher s Guide)

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

Supplementary Table S1: Proportion of missing values presents in the original dataset

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /

Benefit of Performing PCI Based on FFR

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

eucalimus - First Experience

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Mid-term results from real-world REPARA registry. Felipe Hernandez, on behalf of the REPARA investigators

SUPPLEMENTAL MATERIAL

In-Ho Chae. Seoul National University College of Medicine

PCI vs. CABG From BARI to Syntax, Is The Game Over?

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Side Branch Occlusion

STEMI AND MULTIVESSEL CORONARY DISEASE

For Personal Use. Copyright HMP 2013

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

NCVD-PCI Registry. Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association of Malaysia

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

CABG Surgery following STEMI

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Declaration of conflict of interest. Nothing to disclose

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &

Δημήτριος Αγγοσράς, FETCS

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

EXAMINATION trial. Manel Sabaté Hospital Clínic, Barcelona (On behalf of the Examination Investigators)

FFR in Multivessel Disease

Non ST Elevation-ACS. Michael W. Cammarata, MD

CASE from South Korea

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Upgrade of Recommendation

Chronic Total Occlusion: A case for coronary artery bypass grafting

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Supplementary Material to Mayer et al. A comparative cohort study on personalised

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

Count Down to COMBAT

What is new in the Treatment of STEMI? Malcolm R. Bell, MBBS Mayo Clinic Rochester, MN

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Contrast Induced Nephropathy

Modeling and Risk Prediction in the Current Era of Interventional Cardiology

What do the guidelines say?

ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trial

Declaration of conflict of interest NONE

Myocardial Infarction In Dr.Yahya Kiwan

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease

Acute Myocardial Infarction

Prevalence and Impact of Renal Insufficiency on Clinical Outcomes of Patients Undergoing Coronary Revascularization

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Randomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction

Coronary interventions

National Intervention Council

Controversies in Cardiac Surgery

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

Transcription:

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell Medical College New York Presbyterian Hospital

RCA on Presentation

LCX on Presentation

LAD on Presentation

History 34-year old man PMH: current smoker; no other medical conditions or medications; no illicit drug use FH: (+) premature CAD, with father having MI at age 44 (+) troponin level; no ECG changes What is the appropriate treatment?

LCX post Stenting

LAD post Stenting

RCA post Stenting

Background Conventional strategy for primary or rescue angioplasty during acute myocardial infarction (AMI) is angioplasty (PCI) of the infarct-related vessel only regardless of the number of diseased vessels. However, recent studies suggest that acute coronary syndromes, including AMI, may result from a systemic inflammatory process, causing multiple unstable lesions. Many angiographic studies have documented that at least 50% of patients with AMI have multi-vessel CAD. Thus, a strategy of multi-vessel angioplasty in the periinfarct period may be important in improving the outcomes of primary angioplasty.

Pros and Cons of Multi-vessel PCI during AMI Pros Complete revascularization, obviating the need for repeat interventions Compensatory hyperkinesis to maintain left ventricular function Prevention of recurrent ischemia or infarction Improved left ventricular function and survival Cons Potentially increased procedural risks Contrast volume Higher late TVR and MACE Unnecessary revascularization

Purpose To determine the feasibility and safety of multi-vessel PCI compared to single-vessel PCI in patients with AMI and multi-vessel (>70% stenosis in at least 2 major coronary arteries).

Methods Using the 2000-2001 New York State Angioplasty Registry database, we retrospectively compared inhospital clinical outcomes in patients with multi-vessel disease who underwent single vessel, infarct-related vessel PCI only versus multi-vessel PCI within 24 hours of AMI. Patients with cardiogenic shock or hemodynamic instability, prior myocardial infarction, PCI, or coronary artery bypass surgery were excluded from the analysis.

Methods Multivessel disease was defined as having > 70% stenosis in at least two major coronary arteries. Post procedural major adverse cardiac events (MACE) were defined as in-hospital death, stroke, or need for emergent coronary artery bypass surgery. Other outcome measures included length of stay and renal failure requiring dialysis.

Results:Baseline Characteristics Single-vessel PCI Multi-vessel PCI P Value (N=1381) (N=642) Age (years) 62.3±13.1 60.0±12.4 0.018 Male (%) 71.9 77.3 0.010 Hypertension (%) 61.0 62.0 NS Diabetes (%) 20.7 16.7 0.035 Tobacco use (%) 35.5 37.4 NS Prior stroke (%) 4.1 1.2 0.001 Chronic renal failure*(%) 17.0 13.0 NS Peripheral vascular disease(%) 8.8 4.7 0.001 * Chronic renal failure: serum creatinine >2.5 mg/dl or dependence on peritoneal or hemodialysis

Results:Procedural Characteristics Single vessel PCI Multi vessel PCI P Value (N=1381) (N=642) Congestive heart failure (%) 8.3 6.7 NS Ejection Fraction (%) 46.4±11.1 48.2±10.6 NS GP IIb/IIIa inhibitor therapy (%) 77.0 77.3 NS Thrombolytic therapy (%) 19.8 21.3 NS PCI total occlusion (%) 52.4 41.9 <0.001 PCI proximal LAD (%) 20.8 28.0 <0.001 Proximal LAD lesion present, no PCI (%) 7.5 0.9 <0.001 Stent (%) 90.9 98.9 <0.001

Results:Angiographic Characteristics Single vessel PCI Multi vessel PCI P Value (N=1381) (N=642) Number of lesions >70%, per patient 3.2 3.5 <0.001 Lesion Type per group (%) A 12.4 8.5 <0.001 B 60.8 67.3 <0.001 C 26.8 24.2 <0.001 Total lesions treated/lesions present (%) 2416/4482 (53.9) 2109/2242 (94.1) <0.001

Results In-hospital outcomes Prevalence (%) 5 4 3 2 1 4.6 * 2.5 2.5 * * p<0.05 0.8 0.8 0.5 1.1 0.8 0 Single vessel PCI (n=1381) Multi-vessel PCI (n=642) MACE Death Emergent CABG Stroke

Results There were no differences between the groups in: acute occlusion or stent thrombosis (0.7% versus 0.9%) acute renal failure requiring dialysis (0.2% versus 0.3%) length of stay (5.4 versus 5.3 days).

Results Independent predictors of mortality Multi-vessel PCI Proximal LAD lesion Congestive heart failure Increasing Age 0.24 1.04 2.45 3.07 0 1 2 3 4 5 6 7 8

Conclusions Despite the added complexity of multi-vessel PCI, patients in this group had significantly lower inhospital mortality. A strategy of multi-vessel PCI during AMI may be safe compared with infarct-related artery angioplasty in selected patients.